HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

Benzinga · 06/03 11:42
HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.